2018-04-20                     Senate Journal                      Page 2801
HB 240                                                                                                                        
The Finance Committee considered CS FOR HOUSE BILL                                                                              
NO. 240(FIN) "An Act relating to prescription prices available to                                                               
consumers; relating to penalties for certain pharmacy or pharmacist                                                             
violations; relating to the registration and duties of pharmacy benefits                                                        
managers; relating to procedures, guidelines, and enforcement                                                                   
mechanisms for pharmacy audits; relating to the cost of multi-source                                                            
generic drugs and insurance reimbursement procedures; relating to the                                                           
duties of the director of the division of insurance; and providing for an                                                       
effective date." Signing do pass: Senators MacKinnon, Hoffman,                                                                  
Cochairs; Senators Bishop, von Imhof, Stevens, Micciche. Signing no                                                             
recommendation: Senator Olson.                                                                                                  
                                                                                                                                
The following fiscal information was published today:                                                                           
     Fiscal Note No. 4, zero, Office of the Governor                                                                            
                                                                                                                                
The bill was referred to the Rules Committee.